Monopar Therapeutics (MNPR) said Friday it has priced an offering of shares and and pre-funded warrants to raise $40 million.
Monopar said it priced the underwritten registered offering of 798,655 shares at $23.79 per share and the private placement of warrants to purchase 882,761 shares at $23.789 per pre-funded warrant.
The offering is set to close Monday, with Piper Sandler as the book-running manager, the clinical-stage company. It plans to use the proceeds for general corporate purposes and working capital.
Monopar shares were up about 2% in recent trading.
Price: 24.29, Change: +0.50, Percent Change: +2.09
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments